Search published articles


Showing 2 results for Business Model

Hossein Dargahi, Nilufar Mohammad Zadeh, Hamid Reza Rezaian,
Volume 5, Issue 3 (11-2011)
Abstract

Background and Aim: The use of electronic operations in health care industry has many positive points such as health care quality improvement, reduction in costs, and increased efficiency. Besides talking about the concept of Mobile Commerce (M-Commerce) as well as its benefits and challenges, the present article presents suitable approaches to benefit more from this new technology in the field of health, especially in the private sector.

Materials and Methods: This review article was performed based on a literature review and a search through such valid sites as Science Direct, Emerald, and Magiran, and also an advanced search in Google. In this paper, the researchers studied national and international documents about the application of communication and IT tools -- particularly mobile and wireless tools, E-commerce, and M-commerce -- from 1996 to 2011.

Results: E-business can be considered as one of the subsets of E-Health, and M-commerce as one of the E-business models is a very useful tool in developing countries. With this tool, organizations located in remote places can have access to potential customers and gain valuble benefits. Efficient application of E-business models in Iran requires the identification of opportunities and barriers as well as the preparation of suitable and basic plans with regard to socio-economic factors together with the provision of executive, legal, technological, and communications infrastructures.


Maryam Goodarzi, Seyed Soroush Ghazinoori, Reza Radfar, Abbas Kebriaeezadeh,
Volume 13, Issue 5 (1-2020)
Abstract

Background and Aim: Given the increasing variety of biological drugs in the world and the significant role of these drugs in patients' quality of life, as well as the high risk of drug productions, biopharmaceutical companies need to revise their business model. The purpose of this study is to review the dimensions and components of biopharmaceutical companies.
Materials and Methods: This is a comprehensive review and is based on the existing studies by searching valid databases such as PubMed, Science Direct, SID, Iran doc and Google Scholar from 2000 to 2019. All the searches were performed based on keywords such as “Components of Business Model”, and “Business Model of Biopharmaceutical Companies”. The initial search yielded 820 articles. After screening, 23 articles were selected for final study.
Results: The overall dimensions of business model in biopharmaceutical companies are identical to other companies, but the components of the business model of these kinds of companies are various based on their performance, and the most important components include the value proposition, key resources, success factors, revenue stream and cost structure.
Conclusion: Introducing the components of business model in this study can be adjusted based on the dimensions of business model and the characteristics of each biopharmaceutical company.


Page 1 from 1     

© 2024 , Tehran University of Medical Sciences, CC BY-NC 4.0

Designed & Developed by: Yektaweb